FDA Issues Public Health Advisory Recommending Limited Use of Cox-2 Inhibitors
On Dec. 23, 2004, the U.S. Food and Drug Administration (FDA) issued a Public Health Advisory summarizing the agency's recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents.
